Fasting blood sugar levels and diabetes risk
Pro Research Analysisby 
Searched over 200M research papers
Fasting Blood Sugar Levels and Diabetes Risk: Key Insights
Normal and High-Normal Fasting Blood Sugar and Diabetes Risk
Research shows that even fasting plasma glucose (FPG) levels within the normal range can predict future diabetes risk. Individuals with FPG levels at the higher end of the normal range (95–99 mg/dL) are more than twice as likely to develop type 2 diabetes compared to those with levels below 85 mg/dL. The risk increases steadily with each 1 mg/dL rise in FPG, even after accounting for other risk factors like age, BMI, and blood pressure. This means that diabetes risk rises as fasting blood sugar increases, even if it is still considered "normal" by current standards .
Impaired Fasting Glucose and Cumulative Risk
People with impaired fasting glucose (IFG, 100–125 mg/dL) face a much higher risk of developing type 2 diabetes. The risk grows with the number of years a person has IFG: those with persistent IFG over four years have nearly a tenfold higher risk of developing diabetes compared to those who remain normoglycemic. Even intermittent IFG exposure significantly raises diabetes risk .
Low Fasting Blood Sugar and Diabetes Risk
Interestingly, very low fasting plasma glucose levels (<70 mg/dL) are also linked to a higher risk of developing diabetes, as well as increased cardiovascular disease risk. This paradoxical finding suggests that both high and very low fasting glucose levels may signal underlying metabolic issues that increase diabetes risk .
Fasting Blood Sugar, Insulin Resistance, and Pre-Diabetes
In people with pre-diabetes (FPG 100–125 mg/dL), there is a strong positive correlation between fasting blood sugar and fasting insulin levels. This relationship highlights the role of insulin resistance in the progression from pre-diabetes to type 2 diabetes, emphasizing the need for early intervention to prevent disease progression .
Genetic Factors and Fasting Glucose
Genetic studies have identified several gene variants that influence fasting glucose levels and type 2 diabetes risk. Some genetic loci are associated with modest increases in fasting glucose but do not always lead to overt diabetes, suggesting a complex interplay between genetics and blood sugar regulation .
Fasting Blood Sugar and Mortality Risk
Both high and low fasting blood sugar levels are associated with increased risk of death from all causes and cardiovascular events. The lowest mortality risk is seen in people with fasting glucose levels between 80–100 mg/dL. Prediabetes (100–125 mg/dL) is linked to higher mortality, and the negative impact of high fasting glucose on mortality is stronger in younger adults 489.
Fasting Serum Fructose and Diabetes Risk
Elevated fasting serum fructose levels are independently associated with a higher risk of developing type 2 diabetes, suggesting that not only glucose but also other sugars in the blood can serve as early markers or contributors to diabetes risk .
Lifestyle Interventions: Intermittent Fasting
Lifestyle changes, such as intermittent fasting, can help improve fasting blood sugar and other diabetes risk parameters. Personalized approaches, considering factors like weight and age, can optimize the benefits of such interventions for people at risk of diabetes .
Conclusion
Fasting blood sugar is a powerful predictor of diabetes and mortality risk, even within the normal range. Both high-normal and very low fasting glucose levels are linked to increased risk, and cumulative exposure to impaired fasting glucose greatly raises the chance of developing type 2 diabetes. Early identification and intervention, including lifestyle changes, are crucial for reducing diabetes risk and improving long-term health outcomes.
Sources and full results
Most relevant research papers on this topic